$BLTE
Price history, market instrument context, member research, and related headlines in one place.
BLTE key statistics
NasdaqCMUSD
52-week range
$81.0160%$200.00
Latest session $150.02–$154.85Belite Bio, Inc (BLTE) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $152.72, up $0.85 (0.56%) from the previous close of $151.87. It has traded between $150.02 and $154.85 in the latest session. Over the past year it has ranged from $81.01 to $200.00, leaving it in the upper half of its 52-week range (60%). Reported volume for the session was 158.5K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Belite Bio outlines February 12, 2027 PDUFA date for Tinlarebant in Stargardt disease following FDA priority review acceptance — See source for full details.
Belite Bio wins FDA priority review for lead candidate — See source for full details.
Loading $BLTE research…